Morningstar

Avantor® and BlueWhale Bio Partner to Accelerate CAR-T Manufacturing with Breakthrough Cell Activation and Expansion Technology

RADNOR, Pa. and PHILADELPHIA, Oct. 15, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and ...
Hosted on MSN

Avantor and BlueWhale Bio Partner to Accelerate CAR-T Cell Therapy Manufacturing

RADNOR, PA & PHILADELPHIA, PA — Avantor, Inc. (NYSE: AVTR) has entered into a strategic partnership with BlueWhale Bio, a commercial-stage biotechnology firm focused on improving immune cell therapy ...
Business Wire

Taiwan Bio Therapeutics and TRACT Therapeutics Announce Successful Transfer of TRACT’s Regulatory T Cell Platform Technology to Taiwan Bio’s Manufacturing Facility

TAIPEI, Taiwan & CHICAGO--(BUSINESS WIRE)--Taiwan Bio Therapeutics, Inc. and TRACT Therapeutics, Inc. are pleased to announce the successful transfer of TRACT Therapeutics’ innovative regulatory T ...
Nasdaq

Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy manufacturing. The collaboration merges Avantor’s bioprocessing expertise ...
Business Wire

BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell

TOKYO & MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and ...
Supply Chain

Biden Signs Order to Boost Bio-Manufacturing, Compete with China

President Joe Biden signed an executive order laying out a strategy to bolster domestic bio-manufacturing and reduce reliance on China for new medicines, chemicals and other products. Biden signed the ...